These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 23169309)

  • 1. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and colorectal cancer.
    Kraus S; Arber N
    Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation in sporadic colorectal cancer.
    Moossavi S; Bishehsari F
    Arch Iran Med; 2012 Mar; 15(3):166-70. PubMed ID: 22369306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IBD-related carcinoma and lymphoma.
    Claessen MM; Siersema PD; Vleggaar FP
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S27-38. PubMed ID: 21640928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
    Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
    Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
    Itzkowitz SH; Yio X
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development.
    Waldner MJ; Neurath MF
    Semin Immunol; 2014 Feb; 26(1):75-9. PubMed ID: 24447345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplasia and cancer in inflammatory bowel disease.
    Basseri RJ; Basseri B; Papadakis KA
    Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
    Yashiro M
    Dig Dis Sci; 2015 Aug; 60(8):2251-63. PubMed ID: 25840920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications.
    Goel GA; Kandiel A; Achkar JP; Lashner B
    Am J Gastroenterol; 2011 Apr; 106(4):719-30. PubMed ID: 21386829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucins in inflammatory bowel diseases and colorectal cancer.
    Sheng YH; Hasnain SZ; Florin TH; McGuckin MA
    J Gastroenterol Hepatol; 2012 Jan; 27(1):28-38. PubMed ID: 21913981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of cysteinyl leukotrienes in chronic inflammation and neoplasia of the intestine].
    Broom OJ; Nielsen OH
    Ugeskr Laeger; 2009 Jan; 171(4):243-6. PubMed ID: 19174041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology.
    Matkowskyj KA; Chen ZE; Rao MS; Yang GY
    Arch Pathol Lab Med; 2013 Mar; 137(3):338-50. PubMed ID: 23451745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
    Triantafillidis JK; Nasioulas G; Kosmidis PA
    Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large Bowel Genetic Background and Inflammatory Processes in Carcinogenesis--Systematic Review.
    Szylberg Ł; Janiczek M; Popiel A; Marszałek A
    Adv Clin Exp Med; 2015; 24(4):555-63. PubMed ID: 26469098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer surveillance in inflammatory bowel disease: new molecular approaches.
    Risques RA; Rabinovitch PS; Brentnall TA
    Curr Opin Gastroenterol; 2006 Jul; 22(4):382-90. PubMed ID: 16760754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
    Herszényi L; Barabás L; Miheller P; Tulassay Z
    Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer.
    Luo C; Zhang H
    Mediators Inflamm; 2017; 2017():5126048. PubMed ID: 28852270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.